About | Free Trial

Last Update

2015-10-18T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Donald Marvin?

Mr. Donald Marvin R.

Chief Financial Officer

Orchid Cellmark Inc

HQ Phone: (609) 750-2200

Orchid Cellmark Inc

4390 U.S. Route One

Princeton, New Jersey 08540

United States

Company Description

Orchid Cellmark Inc. is engaged in the provision of deoxyribonucleic acid (DNA) testing services that generate genetic profile information by analyzing an organism�s genetic identity. It also provides non-DNA forensic laboratory services. The Company�s bu ... more

Find other employees at this company (144)

Background Information

Employment History

President and Chief Executive Officer
Inocucor Technologies Inc

President and Chief Executive Officer
IdentiGEN Ltd.

President and Chief Executive Officer
Cairns & Associates P.C

Affiliations

Board Member
Microbiome Therapeutics LLC

Founder
Cairns & Associates P.C

Board Member
MBT

Board Member
Tepnel Life Sciences PLC

Education

B.S.
microbiology
Ohio State University

B.S.
microbiology
The Ohio State University

B.S. degree

Ohio State

M.B.A.
microbiology
The Ohio State University

M.B.A.
organizational behavior and finance
Iona College

Web References (194 Total References)


Cycle Capital also helped ...

inocucor.com, $reference.date [cached]

Cycle Capital also helped Inocucor find a professional chief executive - Donald R. Marvin, who is best known for co-founding Orchid BioSciences, the largest private DNA testing firm in the world. Marvin moved from Colorado to head the company. He said memories of growing up near his grandfather's farm in northeast Ohio inspired him to return to the agricultural industry. "All these years later I've sort of come full circle," Marvin said, adding "I'm back developing great products for farmers and growers out there to help feed the world."

Inocucor recently launched a $15-million equity financing, which it expects to complete in the second half of 2015. The company's shareholders now include Desjardins-Innovatech, Inocucor's employees and a small group of angel investors.
There are currently 22 employees, but Marvin expects that number to grow to more than 100 in the next two years.
...
While the company is not yet turning a profit, Marvin said it could be worth up to $400 million in the coming years. "It's not about the revenue per se that creates value in this company, it's the underlying intellectual property," he said.
The company will make acquisitions in the near future to bring new products and technology into its lineup, Marvin said. "You could expect to see something in the next couple months," he noted.


Attracted internationally recognized ...

inocucor.com, $reference.date [cached]

Attracted internationally recognized bioscience veteran Donald R. Marvin as President and CEO. Marvin is best known for co-founding Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing. Participated in the 2014 Ag Innovation Showcase in St. Louis, Missouri, one of the premier events connecting agriculture's innovators and investors.


Cycle Capital also helped ...

inocucor.com, $reference.date [cached]

Cycle Capital also helped Inocucor find a professional chief executive - Donald R. Marvin, who is best known for co-founding Orchid BioSciences, the largest private DNA testing firm in the world. Marvin moved from Colorado to head the company. He said memories of growing up near his grandfather's farm in northeast Ohio inspired him to return to the agricultural industry. "All these years later I've sort of come full circle," Marvin said, adding "I'm back developing great products for farmers and growers out there to help feed the world."

Inocucor recently launched a $15-million equity financing, which it expects to complete in the second half of 2015. The company's shareholders now include Desjardins-Innovatech, Inocucor's employees and a small group of angel investors.
There are currently 22 employees, but Marvin expects that number to grow to more than 100 in the next two years.
...
While the company is not yet turning a profit, Marvin said it could be worth up to $400 million in the coming years. "It's not about the revenue per se that creates value in this company, it's the underlying intellectual property," he said.
The company will make acquisitions in the near future to bring new products and technology into its lineup, Marvin said. "You could expect to see something in the next couple months," he noted.


Board of Directors | Microbiome Therapeutics

www.mbiome.com, $reference.date [cached]

Donald R. Marvin, M.B.A. - Director

Independent Director Donald Marvin has over 25 years of leadership experience in the development and commercialization of novel diagnostic and research products. He is President and CEO of Cairn Associates, a life sciences strategy consulting and investment firm. Previously, Mr. Marvin was President and CEO of IdentiGEN, a leading provider of DNA-based solutions in the agriculture and food industries. He was a co-founder, CFO and Senior Vice President of Corporate Development of Orchid BioSciences, a pioneer in human DNA identity testing. Prior to Orchid, Mr. Marvin was President and CEO of Diatron Corp., a developer of fluorescence-based clinical diagnostic systems. Earlier in his career, he held positions in strategic planning, business development, operations and marketing at PepsiCo, Abbott Laboratories, Bayer and Boehringer Ingelheim. Mr. Marvin also serves as a Director of Melior Discovery. He received a B.S. degree from Ohio State University and an M.B.A. from Iona College.


Hobbs & Towne, Inc. | Executive Search News

hobbstowne.com, $reference.date [cached]

Inocucor's President and CEO, Donald R. Marvin, a veteran of the North American bioscience industry, said Blome will bring perspective from his 25 years in mainstream agriculture to Inocucor's board.

...
"The range of potential customers for Inocucor's products is huge," said Marvin.
...
Biotechnology industry veteran Donald R. Marvin has joined Inocucor Technologies, Inc.
Read More
Montreal, QC - Biotechnology industry veteran Donald R. Marvin has joined Inocucor Technologies, Inc., the Montreal-based ag biotech company that develops biological products and processes for agriculture, as President and CEO.
"Inocucor is a leading-edge clean tech company that is destined to make a great contribution to agricultural productivity. Marvin will help the company fully develop the commercial potential of its technology to meet the needs of today's farmers," said Andree-Lise Methot, founder and managing partner of Cycle Capital Management, Inc.
...
Marvin has been an entrepreneur and leader in the commercialization of new life sciences diagnostic and research technologies and products for more than 30 years. He most recently was President and CEO of Cairn Associates Inc., a biotechnology, life science and consumer products strategy development and financial advisory firm.
Prior to that, Marvin was the president and CEO of IdentiGEN, Inc., a leading provider of DNA-based solutions to the agriculture and food industries. He was a co-founder of Nasdaq-traded Orchid BioSciences, a pioneer in human DNA identity testing, where he served as its chief operating officer, chief financial officer and senior vice president of corporate development.
His expertise includes strategic planning, business development, technical administration and operations at PepsiCo, Abbott Laboratories and Bayer AG, as well as domestic and international marketing and sales for the clinical diagnostics subsidiary of Boehringer Ingelheim.
Named New Jersey's CFO of the year in 2001, Marvin is an experienced fundraiser. He has raised over $300 million in private and public financings, and completed nearly a dozen M&A transactions. Marvin has served on the boards of several public and privately held companies and currently serves on the board of MicroBiome Therapeutics, Inc.
He earned a B.S. in microbiology from Ohio State University and an M.B.A. in organizational behavior and finance from Iona College.

Similar Profiles

Other People with this Name (4,567)

Other people with the name Marvin

Josh Marvin
Subaru

Hayes Marvin
TASA Minor Hockey Association

Tom Marvin
Central Indiana Jobs

Vicki Marvin
Church of St. Dominic

Michael Marvin
Flight Centre Limited

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory